Rxsight

Rxsight Long-term Debt

The Long-Term Debt of Rxsight (RXST) as of Nov 22, 2026 is 40.17 M USD. In the previous year, Long-Term Debt was 43.40 M USD — a change of -7.45% (lower).

Long-term Debt

40.17 MUSD

YoY

-7.45%

Last updated:

Long-Term Debt of Rxsight is 2022 40.17 M USD. Long-Term Debt of Rxsight was 2021 43.40 M USD. It decreases by -7.45% lower compared to the previous year.

The Rxsight Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2020
24.40 M USD
Jan 1, 2021
43.40 M USD
Jan 1, 2022
40.17 M USD
The Rxsight Long-term Debt history
YEARLong-term DebtYoY
40.17 MUSD-7.45%
43.40 MUSD+77.88%
24.40 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rxsight Stock analysis

What does Rxsight do? Rxsight Inc is an innovative company that specializes in developing innovative solutions for eye treatments. The company aims to make a positive contribution to the quality of life for patients suffering from eye problems. Rxsight Inc was founded in 2008 by Jim Taylor, who had previously worked in computer graphics at Pixar Animation Studios and was now involved in new technologies for ophthalmology. The business model of Rxsight Inc is based on the development and marketing of medical products that improve the treatment of eye diseases. The company focuses on the field of dynamic ophthalmology, which aims to improve treatment options for eye diseases by focusing on the influence of eye movements and changes in pupil size. Rxsight Inc is divided into various divisions, with an important division focusing on research and development of products that can improve the treatment of eye diseases. The company invests heavily in developing innovative products. Additionally, Rxsight Inc is also involved in the manufacturing and marketing of medical products. Rxsight Inc's products include special contact lenses that can be individually customized through precise measurement of the eye lens. These contact lenses can help patients achieve better visual quality after eye surgery. Rxsight Inc also offers certain measuring devices that are used for measuring and analyzing eye movements and pupil size. Another important product from Rxsight Inc is the "Light Adjustable Lens System," which is a system for intraocular lenses that operates based on feedback from light and energy. The system allows for an individualized process for adjusting the strength of intraocular lenses. With the "Light Adjustable Lens System," patients can achieve significantly improved visual quality after cataract surgery. Overall, Rxsight Inc has established itself as an innovative company in ophthalmology. The company focuses on research and development to provide new technologies for the treatment of eye diseases. Rxsight Inc emphasizes dynamic ophthalmology to consider the influence of eye movements and pupil size in the therapy of eye diseases. With its products, Rxsight Inc makes an important contribution to improving the visual quality of patients. Rxsight is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rxsight stock

Long-Term Debt of Rxsight is 40.17 M USD in 2022.

Long-Term Debt of Rxsight changed from 43.40 M USD to 40.17 M USD, representing a -7.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Rxsight since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Rxsight historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rxsight

All Key Metrics — Rxsight